A detailed history of Ever Source Wealth Advisors, LLC transactions in Repligen Corp stock. As of the latest transaction made, Ever Source Wealth Advisors, LLC holds 37 shares of RGEN stock, worth $4,432. This represents 0.0% of its overall portfolio holdings.

Number of Shares
37
Previous 8 362.5%
Holding current value
$4,432
Previous $1,000 500.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Jun 11, 2024

BUY
$170.78 - $208.42 $4,952 - $6,044
29 Added 362.5%
37 $6,000
Q4 2023

Feb 09, 2024

SELL
$114.17 - $185.35 $3,539 - $5,745
-31 Reduced 79.49%
8 $1,000
Q3 2023

Nov 03, 2023

BUY
$138.78 - $176.51 $4,440 - $5,648
32 Added 457.14%
39 $6,000
Q2 2023

Aug 04, 2023

BUY
$138.42 - $180.31 $968 - $1,262
7 New
7 $0
Q1 2022

May 25, 2022

SELL
$161.19 - $257.96 $967 - $1,547
-6 Closed
0 $0
Q4 2021

Feb 07, 2022

BUY
$247.59 - $304.47 $1,485 - $1,826
6 New
6 $2,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.65B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Ever Source Wealth Advisors, LLC Portfolio

Follow Ever Source Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ever Source Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ever Source Wealth Advisors, LLC with notifications on news.